# Prospective Assessment of TBDx Feasibility

> **NCT02912832** · NA · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 572 (actual)

## Conditions studied

- Pulmonary Tuberculosis

## Interventions

- **DEVICE:** TBDx

## Key facts

- **NCT ID:** NCT02912832
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-03
- **Final completion:** 2015-08
- **Target enrollment:** 572 (ACTUAL)
- **Last updated:** 2016-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02912832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02912832, "Prospective Assessment of TBDx Feasibility". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02912832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*